The eighth version (seventh update) of a living guideline is released. It replaces earlier versions. The latest update includes a strong recommendation for the...
Sotrovimab, a monoclonal antibody already approved for mild to moderate COVID-19 in several countries gets approval by MHRA in the UK. This antibody was intelligently designed...
Routine sero-surveillance of the population to estimate presence of antibodies to COVID-19 is required to understand the development of herd immunity in a population....
University College London Hospitals (UCLH) has announced neutralising antibody trial against COVID-19. The announcement on 25 December 2020 says ‘’UCLH doses first patient in...
Existing biologics such as Canakinumab (monoclonal antibody), Anakinra (monoclonal antibody) and Rilonacept (fusion protein) can be exploited as therapeutics that restrain inflammation in COVID-19...
A unique immunotherapy-based antibody approach has been developed which targets cancers consisting of solid tumours.
Ovarian cancer is the seventh most common cancer in women...